In March 2012, the United States was filed about 12,000 lawsuits against the company, Bayer HealthCare Pharmaceuticals, Inc., manufacturer of Yasmin and other known hormonal contraceptives are associated with increased risk of thrombosis
Thrombosis - the cause of heart attack and stroke
deep vein thrombosis, pulmonary embolism, and gallbladder problems. In addition, Yasmin and other contraceptives containing ethinyl estradiol may cause side effects such as stroke, cerebrovascular accident, heart attack, myocardial infarction, and even death.
By the beginning of March this year Bayer's thousands of lawsuits were filed by people who as a result of receiving Yarin faced with serious health problems. Another several thousand lawsuits accuse Bayer that the fourth-generation contraceptive pill containing progestin drospirenone, lead to the development of gallbladder disease. The main "prosecution" in the latter case is drospirenone - new synthetic analog progestin, which is included in an oral contraceptive in combination with estrogen
Estrogen - the key to bone health
The lawsuits said that Bayer has failed to properly inform patients and doctors about what Yasmin and some other birth control pills have a more serious side effects than some others, Bole safe, contraceptives.
The first meetings were to begin in autumn 2011 (by that time been filed set of claims), but the process was postponed indefinitely. In February 2012, representatives of Bayer announced that they reached an agreement with the plaintiffs on 70 lawsuits over violations of cerebral circulation and pulmonary embolism
Pulmonary embolism - a dangerous violation
. Today, the proceedings are ongoing, and the courts continue to accept claims from women, anyway affected while taking Yasmin.
In 2001, Yasmin was approved by the US to control the quality of food and drugs as contraceptives and medicines for people suffering from premenstrual syndrome (PMS)
. In addition, Yarin prescribed and used for the treatment of moderate acne
. Contraceptives fourth generation from Bayer also used as a remedy for acne and severe PMS
. However, an independent study, which involved nearly one million women showed that contraceptive Bayer significantly less safe than other contraceptives leading manufacturers
. Bayer, despite the lawsuits and proceedings, continues to deny his guilt in the fact that drugs were such side effects
. At the same time, Bayer accused and that their advertising campaign could introduce patients misleading: while promoting Yarin in advertising emphasizes the fact that it helps to get rid of acne and relieve the symptoms of PMS
Women taking Yasmin, you need to know about the symptoms that cause the most dangerous side effects.
Symptoms associated with the formation of blood clots while taking Yasmin may be:
- Sudden severe headache;
- Unusual swelling or pain in the hands and feet;
- Cutting or squeezing pain in the chest
Chest pain is one symptom - a lot of diseases
or coughing up blood;
- Vision problems - such as blurred vision, double vision visible objects, or complete loss of vision;
- Pain in the rear legs.
In addition, since Yasmin has a diuretic effect, it can cause serious problems with the gall bladder. The symptoms of such problems are:
- Pain or discomfort in the upper right abdomen;
Conflicting research results
The scientists who conducted various studies have come to different results with respect to the risks associated with taking Yasmin and other birth control that type.
According to one study, the report of which was published in 2011, women taking Yasmin and other new contraceptives, the risk of blood clots was twice higher than in those taking contraceptives, which include levonorgestrel.
In 2007, however, two studies were found that women taking Yasmin contraceptives and the like, are at greater risk than those who take pills with levonorgestrel. One recent study showed that women who take contraceptives containing drospirenone (one pill Yasmin contains 3 mg of the substance), the likelihood of blood clots in the 1, 5 times higher than those using other hormonal contraceptives.
Conflict of interest
In March this year, the committee of the Office of Food Inspection and Drug Administration voted to Yasmin and other hormonal contraceptives containing drospirenone, remained in the US market. The ratio was 15 votes to 11, and four of their voted to leave the drug on the market, had a connection with the company Bayer. In the near future, probably will take a second vote, without relating to the interested party committee members.